Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls

Background. Ectopic fat deposition in the pancreas and its relationship with hepatic steatosis and insulin resistance have not been compared between patients with nonalcoholic fatty liver disease (NAFLD) and healthy controls. Aim. Using a novel magnetic resonanc...

Full description

Saved in:
Bibliographic Details
Main Authors: Niraj S. Patel, Michael R. Peterson, Grace Y. Lin, Ariel Feldstein, Bernd Schnabl, Ricki Bettencourt, Ekihiro Seki, Claude B. Sirlin, Rohit Loomba
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2013/498296
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545799866679296
author Niraj S. Patel
Michael R. Peterson
Grace Y. Lin
Ariel Feldstein
Bernd Schnabl
Ricki Bettencourt
Ekihiro Seki
Claude B. Sirlin
Rohit Loomba
author_facet Niraj S. Patel
Michael R. Peterson
Grace Y. Lin
Ariel Feldstein
Bernd Schnabl
Ricki Bettencourt
Ekihiro Seki
Claude B. Sirlin
Rohit Loomba
author_sort Niraj S. Patel
collection DOAJ
description Background. Ectopic fat deposition in the pancreas and its relationship with hepatic steatosis and insulin resistance have not been compared between patients with nonalcoholic fatty liver disease (NAFLD) and healthy controls. Aim. Using a novel magnetic resonance imaging (MRI) based biomarker, the proton-density-fat-fraction (MRI-PDFF), we compared pancreatic fat content in patients with biopsy-proven NAFLD to healthy controls and determined whether it is associated with insulin resistance and liver fat content. Methods. This nested case-control study was derived from two prospective studies including 43 patients with biopsy-proven NAFLD and 49 healthy controls who underwent biochemical testing and MRI. Results. Compared to healthy controls, patients with NAFLD had significantly higher pancreatic MRI-PDFF (3.6% versus 8.5%, P value <0.001), and these results remained consistent in multivariable-adjusted models including age, sex, body mass index, and diabetes (P value =0.03). We found a strong correlation between hepatic and pancreatic MRI-PDFF (Spearman correlation, P = 0.57, P value <0.001). Participants with increased insulin resistance determined by homeostatic-model-of-insulin-resistance (HOMA-IR) greater than 2.5 had higher pancreatic (7.3% versus 4.5%, P value =0.015) and liver (13.5% versus 4.0%, P value <0.001) MRI-PDFF. Conclusion. Patients with NAFLD have greater pancreatic fat than normal controls. Insulin resistance is associated with liver and pancreatic fat accumulation.
format Article
id doaj-art-90ac09ade9864c4f829998525dc16e2a
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-90ac09ade9864c4f829998525dc16e2a2025-02-03T07:24:46ZengWileyGastroenterology Research and Practice1687-61211687-630X2013-01-01201310.1155/2013/498296498296Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal ControlsNiraj S. Patel0Michael R. Peterson1Grace Y. Lin2Ariel Feldstein3Bernd Schnabl4Ricki Bettencourt5Ekihiro Seki6Claude B. Sirlin7Rohit Loomba8Division of Internal Medicine, Department of Medicine, University of California at San Diego, UC San Diego Health System, 9500 Gilman Drive, MC 0063, La Jolla, CA 92093, USADepartment of Pathology, University of California at San Diego, UC San Diego Health System, 9500 Gilman Drive, MC 0063, La Jolla, CA 92093, USADepartment of Pathology, University of California at San Diego, UC San Diego Health System, 9500 Gilman Drive, MC 0063, La Jolla, CA 92093, USADivision of Gastroenterology, Department of Pediatrics, University of California at San Diego, UC San Diego Health System, 9500 Gilman Drive, MC 0063, La Jolla, CA 92093, USADivision of Gastroenterology, Department of Medicine, University of California at San Diego, UC San Diego Health System, 9500 Gilman Drive, MC 0063, La Jolla, CA 92093, USADivision of Epidemiology, Department of Family and Preventive Medicine, University of California at San Diego, UC San Diego Health System, 9500 Gilman Drive, MC 0063, La Jolla, CA 92093, USADivision of Gastroenterology, Department of Medicine, University of California at San Diego, UC San Diego Health System, 9500 Gilman Drive, MC 0063, La Jolla, CA 92093, USALiver Imaging Group, Department of Radiology, University of California at San Diego, UC San Diego Health System, 9500 Gilman Drive, MC 0063, La Jolla, CA 92093, USADivision of Gastroenterology, Department of Medicine, University of California at San Diego, UC San Diego Health System, 9500 Gilman Drive, MC 0063, La Jolla, CA 92093, USABackground. Ectopic fat deposition in the pancreas and its relationship with hepatic steatosis and insulin resistance have not been compared between patients with nonalcoholic fatty liver disease (NAFLD) and healthy controls. Aim. Using a novel magnetic resonance imaging (MRI) based biomarker, the proton-density-fat-fraction (MRI-PDFF), we compared pancreatic fat content in patients with biopsy-proven NAFLD to healthy controls and determined whether it is associated with insulin resistance and liver fat content. Methods. This nested case-control study was derived from two prospective studies including 43 patients with biopsy-proven NAFLD and 49 healthy controls who underwent biochemical testing and MRI. Results. Compared to healthy controls, patients with NAFLD had significantly higher pancreatic MRI-PDFF (3.6% versus 8.5%, P value <0.001), and these results remained consistent in multivariable-adjusted models including age, sex, body mass index, and diabetes (P value =0.03). We found a strong correlation between hepatic and pancreatic MRI-PDFF (Spearman correlation, P = 0.57, P value <0.001). Participants with increased insulin resistance determined by homeostatic-model-of-insulin-resistance (HOMA-IR) greater than 2.5 had higher pancreatic (7.3% versus 4.5%, P value =0.015) and liver (13.5% versus 4.0%, P value <0.001) MRI-PDFF. Conclusion. Patients with NAFLD have greater pancreatic fat than normal controls. Insulin resistance is associated with liver and pancreatic fat accumulation.http://dx.doi.org/10.1155/2013/498296
spellingShingle Niraj S. Patel
Michael R. Peterson
Grace Y. Lin
Ariel Feldstein
Bernd Schnabl
Ricki Bettencourt
Ekihiro Seki
Claude B. Sirlin
Rohit Loomba
Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls
Gastroenterology Research and Practice
title Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls
title_full Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls
title_fullStr Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls
title_full_unstemmed Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls
title_short Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls
title_sort insulin resistance increases mri estimated pancreatic fat in nonalcoholic fatty liver disease and normal controls
url http://dx.doi.org/10.1155/2013/498296
work_keys_str_mv AT nirajspatel insulinresistanceincreasesmriestimatedpancreaticfatinnonalcoholicfattyliverdiseaseandnormalcontrols
AT michaelrpeterson insulinresistanceincreasesmriestimatedpancreaticfatinnonalcoholicfattyliverdiseaseandnormalcontrols
AT graceylin insulinresistanceincreasesmriestimatedpancreaticfatinnonalcoholicfattyliverdiseaseandnormalcontrols
AT arielfeldstein insulinresistanceincreasesmriestimatedpancreaticfatinnonalcoholicfattyliverdiseaseandnormalcontrols
AT berndschnabl insulinresistanceincreasesmriestimatedpancreaticfatinnonalcoholicfattyliverdiseaseandnormalcontrols
AT rickibettencourt insulinresistanceincreasesmriestimatedpancreaticfatinnonalcoholicfattyliverdiseaseandnormalcontrols
AT ekihiroseki insulinresistanceincreasesmriestimatedpancreaticfatinnonalcoholicfattyliverdiseaseandnormalcontrols
AT claudebsirlin insulinresistanceincreasesmriestimatedpancreaticfatinnonalcoholicfattyliverdiseaseandnormalcontrols
AT rohitloomba insulinresistanceincreasesmriestimatedpancreaticfatinnonalcoholicfattyliverdiseaseandnormalcontrols